Coloplast A/S - Asset Resilience Ratio
Coloplast A/S (COLO-B) has an Asset Resilience Ratio of -0.07% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Coloplast A/S total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2023)
This chart shows how Coloplast A/S's Asset Resilience Ratio has changed over time. See Coloplast A/S (COLO-B) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Coloplast A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Coloplast A/S market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0% |
| Short-term Investments | Dkr-33.00 Million | -0.07% |
| Total Liquid Assets | Dkr-33.00 Million | -0.07% |
Asset Resilience Insights
- Limited Liquidity: Coloplast A/S maintains only -0.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Coloplast A/S Industry Peers by Asset Resilience Ratio
Compare Coloplast A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Coloplast A/S (2002–2023)
The table below shows the annual Asset Resilience Ratio data for Coloplast A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-09-30 | -0.08% | Dkr-39.00 Million ≈ $-6.10 Million |
Dkr48.16 Billion ≈ $7.53 Billion |
-0.71pp |
| 2022-09-30 | 0.63% | Dkr219.00 Million ≈ $34.26 Million |
Dkr34.96 Billion ≈ $5.47 Billion |
-0.80pp |
| 2021-09-30 | 1.43% | Dkr226.00 Million ≈ $35.36 Million |
Dkr15.84 Billion ≈ $2.48 Billion |
-0.51pp |
| 2020-09-30 | 1.94% | Dkr262.00 Million ≈ $40.99 Million |
Dkr13.50 Billion ≈ $2.11 Billion |
-0.52pp |
| 2019-09-30 | 2.46% | Dkr313.00 Million ≈ $48.97 Million |
Dkr12.73 Billion ≈ $1.99 Billion |
-0.18pp |
| 2018-09-30 | 2.63% | Dkr310.00 Million ≈ $48.50 Million |
Dkr11.77 Billion ≈ $1.84 Billion |
+0.02pp |
| 2017-09-30 | 2.61% | Dkr315.00 Million ≈ $49.28 Million |
Dkr12.05 Billion ≈ $1.89 Billion |
-1.83pp |
| 2016-09-30 | 4.44% | Dkr489.00 Million ≈ $76.51 Million |
Dkr11.01 Billion ≈ $1.72 Billion |
-0.36pp |
| 2015-09-30 | 4.80% | Dkr519.00 Million ≈ $81.20 Million |
Dkr10.82 Billion ≈ $1.69 Billion |
-1.17pp |
| 2014-09-30 | 5.96% | Dkr619.00 Million ≈ $96.85 Million |
Dkr10.38 Billion ≈ $1.62 Billion |
+2.04pp |
| 2013-09-30 | 3.92% | Dkr367.00 Million ≈ $57.42 Million |
Dkr9.36 Billion ≈ $1.47 Billion |
-2.42pp |
| 2012-09-30 | 6.34% | Dkr645.00 Million ≈ $100.91 Million |
Dkr10.18 Billion ≈ $1.59 Billion |
+0.18pp |
| 2011-09-30 | 6.16% | Dkr568.00 Million ≈ $88.87 Million |
Dkr9.22 Billion ≈ $1.44 Billion |
+6.15pp |
| 2010-09-30 | 0.01% | Dkr1.00 Million ≈ $156.46K |
Dkr7.77 Billion ≈ $1.22 Billion |
+0.00pp |
| 2009-09-30 | 0.01% | Dkr1.00 Million ≈ $156.46K |
Dkr7.96 Billion ≈ $1.25 Billion |
-3.85pp |
| 2003-09-30 | 3.86% | Dkr207.00 Million ≈ $32.39 Million |
Dkr5.36 Billion ≈ $838.61 Million |
+3.84pp |
| 2002-09-30 | 0.02% | Dkr1.00 Million ≈ $156.46K |
Dkr4.49 Billion ≈ $702.34 Million |
-- |
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more